Korro Bio (KRRO) Competitors

Phibro Animal Health (NASDAQ:PAHC) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, community ranking, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Do insiders & institutionals believe in PAHC or KRRO?

99.3% of Phibro Animal Health shares are owned by institutional investors. Comparatively, 13.2% of Korro Bio shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by company insiders. Comparatively, 5.4% of Korro Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Which has stronger valuation & earnings, PAHC or KRRO?

Phibro Animal Health has higher revenue and earnings than Korro Bio. Korro Bio is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.11B	0.79	$2.42M	$0.48	45.17
Korro Bio	$2.27M	75.99	-$81.17M	-$9.39	-1.96

Does the MarketBeat Community favor PAHC or KRRO?

Phibro Animal Health received 290 more outperform votes than Korro Bio when rated by MarketBeat users. However, 100.00% of users gave Korro Bio an outperform vote while only 59.96% of users gave Phibro Animal Health an outperform vote.

Company	Underperform	Outperform
Phibro Animal Health	Outperform Votes 316 59.96%	Underperform Votes 211 40.04%
Korro Bio	Outperform Votes 26 100.00%	Underperform Votes No Votes

Does the media favor PAHC or KRRO?

In the previous week, Korro Bio had 10 more articles in the media than Phibro Animal Health. MarketBeat recorded 17 mentions for Korro Bio and 7 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.13 beat Korro Bio's score of 0.32 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Korro Bio	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is PAHC or KRRO more profitable?

Phibro Animal Health has a net margin of 1.75% compared to Korro Bio's net margin of 0.00%. Phibro Animal Health's return on equity of 25.35% beat Korro Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	1.75%	25.35%	6.21%
Korro Bio	N/A	-50.25%	-38.48%

Do analysts prefer PAHC or KRRO?

Phibro Animal Health presently has a consensus price target of $21.00, suggesting a potential downside of 3.14%. Korro Bio has a consensus price target of $136.33, suggesting a potential upside of 641.75%. Given Korro Bio's stronger consensus rating and higher possible upside, analysts plainly believe Korro Bio is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Korro Bio	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Which has more volatility and risk, PAHC or KRRO?

Phibro Animal Health has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500.

Summary

Phibro Animal Health beats Korro Bio on 11 of the 19 factors compared between the two stocks.